Perspective Therapeutics (CATX) Current Leases (2019 - 2026)
Perspective Therapeutics (CATX) reported Current Leases of $1.1 million for Q1 2026, up 9.08% on a YoY basis from $980000.0 in Q1 2025, and up 71.59% sequentially from $623000.0 in Q4 2025.
Perspective Therapeutics (CATX) Current Leases (2019 - 2026) Analysis & Trends
Perspective Therapeutics (CATX) has 8 years of Current Leases data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 9.08% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 9.08% YoY), and the FY2025 full-year result was $623000.0, down 34.9% from the prior year.
- Current Leases rose to $1.1 million in Q1 2026, from $623000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.1 million in Q1 2026 to a low of $46000.0 in Q4 2023.
- A 5-year average of $538500.0 and a median of $458000.0 in 2023 frame the typical range for Current Leases.
- Peak annual rise in Current Leases reached 1980.43% in 2024, while the deepest fall reached 54.29% in 2024.
- Tracing CATX's Current Leases over 5 years: stood at $272000.0 in 2022, then slumped by 83.09% to $46000.0 in 2023, then soared by 1980.43% to $957000.0 in 2024, then plunged by 34.9% to $623000.0 in 2025, then surged by 71.59% to $1.1 million in 2026.
- Business Quant data shows CATX's Current Leases at $1.1 million in Q1 2026, $623000.0 in Q4 2025, and $704000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 20.50 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | - |
| 10 | Perspective Therapeutics | 296.01 Mn | 296.01 Mn | - | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 623,000.00 |
| Sep 30, 2025 | 704,000.00 |
| Jun 30, 2025 | 847,000.00 |
| Mar 31, 2025 | 980,000.00 |
| Dec 31, 2024 | 957,000.00 |
| Sep 30, 2024 | 903,000.00 |
| Jun 30, 2024 | 720,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 293,000.00 |
| Jun 30, 2023 | 262,000.00 |
| Mar 31, 2023 | 280,000.00 |
| Sep 30, 2022 | 272,000.00 |
| Jun 30, 2022 | 268,000.00 |
| Mar 31, 2022 | 264,000.00 |
| Dec 31, 2021 | 260,000.00 |
| Sep 30, 2021 | 256,000.00 |
| Jun 30, 2021 | 252,000.00 |
| Mar 31, 2021 | 249,000.00 |